Author: Youna Angevin-Castro

Edison Group Research Report

Edison has released a report on LTR Pharma, highlighting the clinical validation of SPONTAN as a fast-acting intranasal treatment for erectile dysfunction and its progression toward regulatory submission.   The report also covers our platform expansion into new markets through ROXUS and OROFLOW, alongside portfolio diversification via our recent investment in LevOmega.   The author notes:   “With […]

Conversation Series | Treating Erectile Dysfunction with Melissa Hadley Barrett 

In recognition of September being Sexual Health Awareness Month, we’re pleased to share the latest episode of our Conversation Series, featuring Sexologist and Nurse Practitioner Melissa Hadley Barrett.  In this episode, Melissa explores a range of treatment options for erectile dysfunction (ED) — from oral medications like Viagra and Cialis to injectable therapies and our […]

SPONTAN® achieves 100% patient satisfaction in post-prostatectomy case series

Clinical collaborator and men’s health expert Melissa Hadley Barrett from Make Hard Easy and the Restorative Health Clinic presented a case series at the Asia-Pacific Prostate Cancer Conference (APCC) in Sydney demonstrating the efficacy of SPONTAN in men suffering ED following radical prostatectomy. The results were compelling: 100% patient satisfaction with SPONTAN treatment All patients […]

SPONTAN® Strengthens Commercial Position with 18-Month Shelf Life Achievement 

LTR Pharma has announced that SPONTAN® has achieved an 18-month shelf life under International Council for Harmonisation (ICH) stability conditions – a significant milestone that strengthens its commercial position in the global ED market.  Achieving an 18-month shelf life under ICH standards demonstrates that SPONTAN is ready for large-scale distribution. Specifically, this milestone: Confirms the […]

US Men’s Health Expert, Dr Andrew Sun, Joins LTR Pharma’s Scientific Advisory Board

LTR Pharma is pleased to announce the appointment of Dr Andrew Y. Sun, M.D., a fellowship-trained urologist and nationally recognised expert in male sexual and reproductive medicine, to its Scientific Advisory Board. Based in Texas, Dr Sun brings extensive experience in prescribing PDE5 treatment protocols and will advise on integrating LTR’s intranasal therapies ROXUS ® […]

Dr Amy Pearlman Joins LTR Pharma’s Scientific Advisory Board

Dr Amy Pearlman, M.D., a board-certified urologist and nationally recognised leader in sexual medicine, has joined the LTR Pharma’s Scientific Advisory Board. Dr Pearlman is Co-founder of Prime Institute in Florida and a fellowship-trained specialist in male sexual and hormonal health. She is a former Director of the Men’s Health Program at the University of […]

LTR Pharma Completes Extractables Study Milestone for SPONTAN®

LTR Pharma has completed extractables studies for SPONTAN®, its intranasal spray for erectile dysfunction, with co-development partner Aptar Pharma. All identified compounds were confirmed below ICH safety thresholds. This milestone represents a required step in the Company’s FDA 505(b)(2) regulatory submission pathway. The FDA requires Extractables and Leachables (E&L) studies for all pharmaceutical products to […]

Conversation Series | Lifestyle Factors and Erectile Dysfunction with Melissa Hadley Barrett

In the third episode of our Conversation Series, Sexologist and Nurse Practitioner, Melissa Hadley Barrett reveals the surprising lifestyle factors that significantly impact men’s sexual health.  Melissa explains why smoking is “the biggest penis killer,” how excess weight blocks blood flow, and reveals that for every 16kg a man gains, he can lose up to […]

Distinguished Urological Expert Joins LTR Pharma’s Scientific Advisory Board

LTR Pharma is pleased to announce that Clinical Associate Professor Darren Katz, a renowned urological surgeon and Medical Director of Men’s Health Melbourne, has joined the Company’s Scientific Advisory Board. As Clinical Associate Professor in the Department of Surgery at the University of Melbourne, and Immediate Past Leader of the Andrology Special Advisory Group to […]

SPONTAN® Now Available at TerryWhite Chemmart Pharmacies Nationwide

LTR Pharma is pleased to announce that SPONTAN® is now available through TerryWhite Chemmart’s network of 600+ pharmacies nationwide, marking a pivotal milestone in our patient access strategy. Under our partnership with Symbion, patients with prescriptions from healthcare professionals can now have them filled at participating TerryWhite Chemmart, Pharmacy Choice, and healthSAVE pharmacies across Australia. […]

LTR Pharma Signs Collaborative Development Agreement to Develop a Novel Intranasal Spray for Oesophageal Motility Disorders

LTR Pharma has announced that it has entered into a collaborative development agreement with Strategic Drug Solutions, Inc. (SDS) to co-develop OROFLOW®, a novel intranasal spray for Oesophageal Motility Disorders (OMD). OROFLOW® represents an important expansion of the Company’s nasal spray technology platform, designed to provide rapid symptom relief for patients struggling with swallowing difficulties […]

Conversation Series | Patient Perspectives | Meet Steve Jones

In our latest Conversation Series video, we meet Steve Jones – a prostate cancer survivor whose candid story highlights the profound psychological impact of erectile dysfunction after surgery.  Meet Steve Jones – prostate cancer survivor and sexual health advocate   When Steve Jones was diagnosed with prostate cancer four years ago, at the age of 56, […]

Conversation Series | Mental Impact of Erectile Dysfunction with Melissa Hadley Barrett

In the second video of our Conversation Series, Sexologist and Nurse Practitioner Melissa Hadley Barrett explores the profound psychological impact erectile dysfunction can have on men’s self-esteem and relationships. Melissa shares a moving case study from her practice where erectile dysfunction led to complete relationship breakdown, with the patient withdrawing from all forms of physical […]

LTR Pharma Scientific and Clinical Advisor to present at USANZ 2025 ASM

LTR Pharma has today announced its Chief Scientific and Clinical Advisor, Professor Eric Chung, has been selected to present at USANZ & ANZUNS 2025 ASM to be hosted in Perth from 1-4 March 2025. Co-hosted by the Urological Society of Australian and New Zealand (USANZ) and Australia and New Zealand Urological Nurses Society (ANZUNS), this […]

Conversation Series | Innovations in Treatments for ED with Dr. Tom Silva

In the latest video from our Conversation Series, specialist GP Dr. Tom Silva discusses crucial considerations in clinical practice with regards to ED treatment selection and patient care. Dr. Silva explores how common side effects and delayed action can impact patient confidence, while highlighting how rapid-acting treatments, like SPONTAN, can enhance spontaneity and improve outcomes […]

Medical Forum | The new treatments changing life after prostate cancer

A new Medical Forum article titled ‘The new treatments changing life after prostate cancer’ by journalist Cathy O’Leary has highlighted the need for new Erectile Dysfunction (ED) treatments for men as they navigate the life-changing side effects of prostate cancer treatment. The article features Melissa Hadley Barrett, nurse practitioner, sexologist and founder of the Restorative […]

Quarterly Activities Report and 4C

LTR Pharma has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 31 December 2024. Key highlights from this period include: Breakthrough Final Clinical Data: SPONTAN® achieves 470% faster absorption than oral PDE5 tablets showing it can be effective within 10 minutes Strategic Partnerships: Joint Venture with […]

LTR Pharma Signs National Pharmacy Distribution Agreement with Symbion   

LTR Pharma is pleased to announce it has entered into an agreement with Symbion Pty Ltd, a leading pharmaceutical wholesaler in Australia, to establish national distribution capabilities for SPONTAN®. Under the agreement, Symbion will provide warehousing, inventory management and nationwide distribution services for SPONTAN through its extensive network of distribution centres servicing over 3,900 pharmacies […]